Safety and efficacy of cytoreductive surgery for epithelial ovarian cancer in elderly and high-risk surgical patients

被引:44
|
作者
Sharma, S
Driscoll, D
Odunsi, K
Venkatadri, A
Lele, S
机构
[1] SUNY Buffalo, Grad Sch, Roswell Pk Canc Inst, Div Gynecol Oncol,Dept Surg, Buffalo, NY USA
[2] SUNY Buffalo, Grad Sch, Roswell Pk Canc Inst, Dept Biostat, Buffalo, NY USA
关键词
ovarian cancer; elderly; poor surgical candidates; complications; debulking; cytoreduction;
D O I
10.1016/j.ajog.2005.06.074
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: Surgery is the cornerstone of management in ovarian cancer. However, in high-risk and elderly patients there is a tendency for less aggressive surgery upfront. The aim of this study was to review cytoreductive surgery, with focus on complications and outcomes in patients with Multiple Surgical risk factors. Study design: Charts of patients with ovarian cancer from 1998 to 2002 were retrospectively reviewed. Results: One hundred and forty patients were treated for ovarian cancer. Sixty-three patients (45%) were elderly (>= 65 years), and 69 patients (49%) had comorbidities. Optimal debulking (< 1 cm) was achieved in 123 patients (88%). There was no significant relation between complications and type of procedure, elderly age, comorbidities, or transfusions. Optimally debulked patients had a significantly longer survival than patients with suboptimal debulking (P < .001). Conclusion: Aggressive optimal cytoreduction can be achieved in the majority of patients with multiple surgical risk factors and is associated with a low complication rate. (c) 2005 Mosby, Inc. All rights reserved.
引用
收藏
页码:2077 / 2082
页数:6
相关论文
共 50 条
  • [41] Morbidity of rectosigmoid resection in cytoreductive surgery for ovarian cancer. Risk factor analysis
    Fournier, M.
    Huchon, C.
    Ngo, C.
    Bensaid, C.
    Bats, A. S.
    Combe, P.
    le FrereBelda, M. A.
    Fournier, L.
    Berger, A.
    Lecuru, F.
    EJSO, 2018, 44 (06): : 750 - 753
  • [42] Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection
    Onda, T
    Yoshikawa, H
    Yasugi, T
    Yamada, M
    Matsumoto, K
    Taketani, Y
    BRITISH JOURNAL OF CANCER, 2005, 92 (06) : 1026 - 1032
  • [43] Analysis of NCCN-distress thermometer in patients with ovarian cancer: results of 150 patients prior to cytoreductive ovarian cancer surgery
    Inci, Melisa Guelhan
    Lee, Marlene
    Woopen, Hannah
    Richter, Rolf
    Goerling, Ute
    Sehouli, Jalid
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2023, 44 (04) : 6 - 13
  • [44] Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection
    T Onda
    H Yoshikawa
    T Yasugi
    M Yamada
    K Matsumoto
    Y Taketani
    British Journal of Cancer, 2005, 92 : 1026 - 1032
  • [45] Management of morbidity associated with pancreatic resection during cytoreductive surgery for epithelial ovarian cancer: A systematic review
    Di Donato, Violante
    Bardhi, Erlisa
    Tramontano, Luca
    Capomacchia, Filippo Maria
    Palaia, Innocenza
    Perniola, Giorgia
    Plotti, Francesco
    Angioli, Roberto
    Giancotti, Antonella
    Muzii, Ludovico
    Panici, Pierluigi Benedetti
    EJSO, 2020, 46 (04): : 694 - 702
  • [46] Optimal cytoreductive surgery is an independent prognostic indicator in stage IV epithelial ovarian cancer with hepatic metastases
    Naik, R
    Nordin, A
    Cross, PA
    Hemming, D
    Lopes, AD
    Monaghan, JM
    GYNECOLOGIC ONCOLOGY, 2000, 78 (02) : 171 - 175
  • [47] Surgical efficacy and quality of wide resection of the pelvic peritoneum in patients with epithelial ovarian cancer
    Nishimura, Akiho
    Motohara, Takeshi
    Morinaga, Jun
    Iwagoi, Yutaka
    Yamamoto, Mayuko
    Yamaguchi, Munekage
    Miyahara, Yo
    Tashiro, Hironori
    Katabuchi, Hidetaka
    SURGICAL ONCOLOGY-OXFORD, 2023, 48
  • [48] Efficacy and safety of decitabine combined with arsenic trioxide in elderly high-risk myelodysplastic neoplasm patients: a retrospective study
    Yang, Jianzhong
    HEMATOLOGY, 2025, 30 (01)
  • [49] Outcomes for Elderly Ovarian Cancer Patients Treated with Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)
    Zambrano-Vera, Katherin
    Sardi, Armando
    Lopez-Ramirez, Felipe
    Sittig, Michelle
    Munoz-Zuluaga, Carlos
    Nieroda, Carol
    Gushchin, Vadim
    Diaz-Montes, Teresa
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (08) : 4655 - 4666
  • [50] Peritoneal VEGF burden as a predictor of cytoreductive surgery outcome in women with epithelial ovarian cancer
    Diniz Bizzo, Solange Maria
    Meira, Debora Dummer
    Lima, Jose Marinaldo
    Mororo, Janio da Silva
    Casali-da-Rocha, Jose Claudio
    Faria Ornellas, Maria Helena
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2010, 109 (02) : 113 - 117